New Blood Tests for Colorectal Cancer Covered by Medicare
This act introduces coverage for new, approved blood-based tests for early detection of colorectal cancer under the Medicare program. The goal is to increase screening participation, especially in underserved communities, and to offset declines in screenings caused by the COVID-19 pandemic. This provides Medicare beneficiaries with access to a less invasive method for early disease detection.
Key points
Medicare will cover FDA-approved blood-based tests for early colorectal cancer detection.
The act aims to increase screening participation, particularly in under-screened communities.
It establishes frequency limits for various colorectal cancer screening tests under Medicare.
Expired
Citizen Poll